Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Vanderbilt University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1873-01-01

Employees: 10K

Market Cap: -

Website: http://www.vanderbilt.edu

Clinical Trials

Efficacy of Lansoprazole in Chronic Post Nasal Drip

Phase 3

Completed

Conditions: Larynx Disease

Interventions: Drug: Lansoprazole Tablet
Procedure: PH and impedence testing
Procedure: manometry
Drug: placebo
Drug: lansoprazole

First Posted Date: 2006-06-09

Last Posted Date: 2012-08-21

Lead Sponsor: Vanderbilt University

Target Recruit Count: 75

Registration Number: NCT00335283

Locations: 🇺🇸
Vanderbilt University Medical Center, Vanderbilt Digestive Disease Clinic, TVC, Room 1660, Nashville, Tennessee, United States

Improving Care for Patients With Diabetes and Poor Numeracy Skills

Not Applicable

Completed

Conditions: Diabetes

Interventions: Behavioral: Control Group
Behavioral: Literacy/Numeracy oriented educational intervention

First Posted Date: 2006-04-06

Last Posted Date: 2008-02-18

Lead Sponsor: Vanderbilt University

Target Recruit Count: 106

Registration Number: NCT00311922

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Hydroxychloroquine in Cystic Fibrosis

Phase 1

Completed

Conditions: Cystic Fibrosis

First Posted Date: 2006-04-06

Last Posted Date: 2008-01-30

Lead Sponsor: Vanderbilt University

Target Recruit Count: 20

Registration Number: NCT00311883

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)

Phase 2

Completed

Conditions: Chronic Kidney Disease

Interventions: Drug: Alpha, gamma, beta, and delta (mixed) tocopherols
Drug: placebo
Drug: alpha lipoic acid

First Posted Date: 2006-03-30

Last Posted Date: 2009-07-09

Lead Sponsor: Vanderbilt University

Target Recruit Count: 62

Registration Number: NCT00308971

Locations: 🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation

Phase 4

Completed

Conditions: Kidney Transplantation

First Posted Date: 2006-03-21

Last Posted Date: 2006-03-21

Lead Sponsor: Vanderbilt University

Target Recruit Count: 80

Registration Number: NCT00305396

Locations: 🇺🇸
Vanderbilt University Medical Center/Nashville VA, Nashville, Tennessee, United States

Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging

Not Applicable

Completed

Conditions: Schizoaffective Disorder
Hallucinations
Schizophrenia

Interventions: Device: functional magnetic resonance imaging

First Posted Date: 2006-02-07

Last Posted Date: 2017-04-19

Lead Sponsor: Vanderbilt University

Target Recruit Count: 60

Registration Number: NCT00288340

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Prevalence of Spasticity in Adults With Mental Retardation Living in the Community

Completed

Conditions: Mental Retardation
Spasticity

First Posted Date: 2006-01-25

Last Posted Date: 2008-03-28

Lead Sponsor: Vanderbilt University

Target Recruit Count: 7

Registration Number: NCT00282191

Locations: 🇺🇸
Homes, Davidson County, Tennessee, United States

Center for Reducing Asthma Disparities - Meharry/Vanderbilt Centers

Completed

Conditions: Asthma
Lung Diseases

First Posted Date: 2006-01-24

Last Posted Date: 2014-12-11

Lead Sponsor: Vanderbilt University

Target Recruit Count: 180

Registration Number: NCT00281151

Locations: 🇺🇸
Meharry Medical School, Nashville, Tennessee, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Botox vs. Baclofen for Upper Limb Spasticity

Phase 1

Terminated

Conditions: Spasticity

Interventions: Drug: intramuscular Botox versus oral baclofen

First Posted Date: 2006-01-20

Last Posted Date: 2012-01-20

Lead Sponsor: Vanderbilt University

Target Recruit Count: 8

Registration Number: NCT00280280

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

Selenium Supplementation of Patients With Cirrhosis

Not Applicable

Terminated

Conditions: Liver Disease

Interventions: Dietary Supplement: 200 µg selenium as selenate
Dietary Supplement: 400 µg selenium as selenate
Dietary Supplement: 200 µg selenium as selenomethionine
Dietary Supplement: Placebo

First Posted Date: 2005-12-30

Last Posted Date: 2012-03-07

Lead Sponsor: Vanderbilt University

Target Recruit Count: 99

Registration Number: NCT00271245

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy